Inhibition of glucose utilization in uremia by hippurate: liquid chromatographic isolation and mass spectrometric and nuclear magnetic resonance spectroscopic identification

scientific article published on 01 May 1989

Inhibition of glucose utilization in uremia by hippurate: liquid chromatographic isolation and mass spectrometric and nuclear magnetic resonance spectroscopic identification is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0378-4347(00)82773-5
P698PubMed publication ID2760149

P2093author name stringV Spustová
P Cernay
I Golier
P2860cites workToxins and inhibitors in chronic renal failureQ39731142
The isolation of an inhibitor of glucose utilization from the serum of uraemic subjectsQ48651823
Influence of organic acids on intracellular pH.Q52702895
Insulin resistance in uremia mediated by postbinding defects.Q54515732
Isolation and chemical identification of inhibitors of plasma ligand bindingQ69668171
Somatomedin inhibitor in uremiaQ70382350
P433issue1
P921main subjecturemiaQ13365776
P304page(s)186-192
P577publication date1989-05-01
P1476titleInhibition of glucose utilization in uremia by hippurate: liquid chromatographic isolation and mass spectrometric and nuclear magnetic resonance spectroscopic identification
P478volume490

Reverse relations

cites work (P2860)
Q47216784Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
Q73957497Dietary protein restriction in combination with angiotensin converting enzyme inhibitor improves insulin resistance in patients with chronic renal disease
Q54153329Inhibition of glucose uptake by 5-hydroxyindoleacetic acid in the isolated rat soleus muscle.
Q68883974Isolation of an additional inhibitor of glucose utilization in renal insufficiency: pseudouridine